Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

The compound was successfully made and shows potential for treating prostate cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Early hair loss may indicate prostate issues.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Male pattern baldness does not cause an increased risk of prostate cancer.

Hair loss linked to prostate enlargement; stress and family history important factors.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.